One-year results show improvement of severe tricuspid regurgitation and quality-of-life improvements with transcatheter edge-to-edge repair in a select patient population.
Final COAPT Results Show TEER Benefits Through 5 Years in Secondary MR
Positive 5-year data argue for early identification and treatment of symptomatic patients in whom transcatheter edge-to-edge repair is appropriate for heart failure with secondary mitral regurgitation.
PRIMARY Trial Aims to Guide Choice of Percutaneous Vs. Surgical Repair of Degenerative Mitral Regurgitation
The new NIH-funded multicenter investigation will help determine which therapy — MitraClip or surgery — is better in which patient types.